Andrew is an experienced corporate lawyer and strategic adviser.
He specialises in mergers and acquisitions, with a focus on advising Australian and international private equity and growth equity funds on their investments and divestments in the Australian market. Andrew's experience also extends to advising family offices and venture capital funds across a range of industry and business sectors, including retail, technology and consumables.
Andrew also advises clients on general corporate and securities laws matters, and frequently works with international clients on their in-bound transactions into the Australian market.
Andrew is a highly pragmatic and commercial lawyer. He marries strong technical knowledge with commercial nous to provide unique value and insight. I consider him a trusted partner.
Andrew can provide clients with the desirable combination of high quality legal advice with a sound, pragmatic commercial overlay, I value his advice.
Andrew is 100% committed to the matter with exceptional legal knowledge and a commercial approach to achieving the most desirable outcome for his client. A lawyer that you can trust.
Advised leading global growth equity investor FTV Capital on its majority investment into medical technology company VALD and on all Australian aspects of its acquisition of Orbus Software.
Advised Anchorage Capital Partners on its acquisitions of HMA Group, AWCON, Entag, Rubicon8, David Jones, South Pacific Laundry and Scotts Refrigerated Logistics as well as its exits from Affinity Education Group, Facilities First, Brand Collective, Solgen, Dick Smith, Contract Resources and Acrow Formwork and Scaffolding.
Advised Five V on its investments in industrial hydraulics businesses Questas and Custom Fluid Power, and technology businesses Checkbox, EngageRM, 1Breadcrumb and Attekus.
Advised Adamantem Capital on numerous transactions, including investments and exists from HyGain (including Mitavite) and Servian.
Advised Cinven and associated funds on the Australian aspects of its acquisition of BioAgilytix, a leading Australian-based CRO, and Archer Technologies, a global integrated risk management platform.
Advised BlackRock on the establishment of its investment structures and joint venture arrangements with Federation Asset Management and multiple platforms with Wentworth Capital and Mayfair Group.